Anti-money Laundering Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development

 Anti-money Laundering Market Growth & Trends

The global anti-money laundering market size is expected to reach USD 3.19 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 15.6% from 2021 to 2028. The growth can be attributed to the growing volume of non-cash transactions, coupled with a rise in technological developments in the fintech sector. In recent years, banks have increased their IT expenditure toward the adoption of advanced solutions and technologies to improve the security of their services and products.

The rapid developments in artificial intelligence, big data, machine learning, and other technologies are creating new opportunities for the market. The rising risk of financial crimes and fraudulent transactions, arising from factors such as the vulnerabilities inherent to digitization and automation, is compelling financial institutions to employ technologies such as machine learning for identifying suspicious transactions on a real-time basis. As a result, various companies are making efforts to deploy machine learning capabilities in anti money laundering solutions. For instance, in November 2020, Computer Services, Inc., a provider of end-to-end regtech and fintech solutions, announced a partnership with Featurespace, an enterprise financial crime prevention software provider. Through this partnership, the companies launched the WatchDOG AML, which uses machine learning capabilities to identify suspicious activities on a real-time basis.

Government bodies across the world are making efforts to promote awareness about anti money laundering regulations. For instance, in 2019, the New Zealand government spent USD 1.083 million on Keep Our Money Clean, an anti money laundering campaign. Through this campaign, the government tried to create public awareness regarding the legislative changes in anti money laundering acts to enable related businesses to educate their customers about new obligations.

The COVID-19 pandemic is anticipated to impact the market growth favorably in near future. The pandemic has led to an increase in the use of mobile-based payment solutions, remote work, and online sales, which are some of the major factors driving the demand for anti money laundering solutions globally. Financial Action Task Force an intergovernmental organization has encouraged financial institutions to provide risk-based flexibility in the implementation of anti money laundering in response to the effects of the pandemic.

Request a free sample copy or view report summary: Anti-money Laundering Market Report

Anti-money Laundering Market Report Highlights

• In terms of component, the software segment is expected to retain its dominance over the forecast period. This can be attributed to the fact that software can help organizations reduce the legal risk associated with money laundering activities
• In terms of product type, the customer identity management segment dominated the market in 2020 and is expected to witness promising growth during the forecast period as well. Advancements in technologies that can easily access an individuals' personal information have increased the demand for customer identity management solutions
• In terms of deployment, the on-premise segment dominated the market in 2020. The on-premise deployment of anti money laundering solutions grants businesses full control over the applications, platforms, systems, and data that their in-house IT teams can handle
• In terms of end use, the BFSI segment dominated the market in 2020. The BFSI sector is widely adopting anti money laundering solutions as they help financial institutions to efficiently comply with national and international regulations as well as provide secured services to customers
• Increasing money laundering cases in emerging economies, such as China and India, are expected to create growth opportunities for the market in the Asia Pacific region over the forecast period

Anti Money Laundering Market Segmentation

Grand View Research has segmented the global anti-money laundering market on the basis of component, product type, deployment, end-use, and region:

Anti-money Laundering Component Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Services

Anti-money Laundering Product Type Outlook (Revenue, USD Million, 2016 - 2028)

• Compliance Management
• Currency Transaction Reporting
• Customer Identity Management
• Transaction Monitoring

Anti-money Laundering Deployment Outlook (Revenue, USD Million, 2016 - 2028)

• Cloud
• On-premise

Anti-money Laundering End-use Outlook (Revenue, USD Million, 2016 - 2028)

• BFSI
• Government
• Healthcare
• IT & Telecom
• Others

Anti-money Laundering Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

List of Key Players of Anti-money Laundering Market

• NICE Actimize
• Tata Consultancy Services Limited
• Trulioo
• Cognizant Technology Solutions Corporation
• ACI Worldwide, Inc.
• SAS Institute Inc.
• Fiserv, Inc.
• Oracle Corporation
• BAE Systems
• Accenture

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nicotine Replacement Therapy Market Estimated to Experience a Hike in Growth by 2028

 Nicotine Replacement Therapy Market Growth & Trends

The global nicotine replacement therapy market size is expected to reach USD 147.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.3% from 2021 to 2028. The growth of the market is largely attributed to increasing government initiatives to promote nicotine replacement therapy (NRT) products for reducing mortality due to smoking and diseases associated with it.

Smoking cessation campaigns are also playing a crucial role in increasing awareness about diseases that are caused because of smoking. These campaigns are run by regional governments as well as multinational companies, such as Philip Morris International and Altria. Global organizations like the WHO are also working toward creating awareness by running online campaigns. 

There has been an exponential increase in the usage of NRT products. The young population is the largest consumer of advanced NRT products, like heat-not-burn tobacco and e-cigarettes. However, middle-aged patients’ interest in smoking cessation has led to a rise in the usage of e-cigarettes. For instance, the use of e-cigarettes for smoking cessation increased to 20% in 2018 from 13% in 2016 among people aged 45 to 54 years.

Furthermore, researchers found that 5% to 9% of smokers tend to use nicotine patches even after the therapeutic period of 12 weeks. The passive approach of combining nicotine patches with a gum, inhaler, or spray is found to be more effective, and quitting rate reaching 34% to 54%. NRT is only recognized as a way of curbing nicotine cravings and treatment by consumers.

With technological advancements, the players in this market are also developing products to suit the changing consumer preferences. For instance, the e-cigarette market is changing with newer innovations that are more efficient, have longer battery life, and are rechargeable. The existing innovations like sleek and easy-to-use socially acceptable e-cigarettes brought a revolution, which drove more people to shift to using NRTs without social stigma.

Various players such as Nicocigs Ltd.; Nicoventures Ltd.; Victory Electronic Cigarettes Corp.; DuraSmoke; AlternaCig; Shenzhen IVPS Technology CO. Limited; and Vapor Group, Inc. are launching e-cigarettes and related products. Although there are hundreds of companies selling e-cigarettes, their usage in NRT is disputed.

Request a free sample copy or view report summary: Nicotine Replacement Therapy Market Report

Nicotine Replacement Therapy Market Report Highlights

• By product, the e-cigarettes segment held the largest NRT market share in 2020 due to increasing investments and the rising focus of companies on developing value-added products. The heat-not-burn tobacco products segment is expected to grow at the fastest rate over the forecast period
• The offline distribution channel segment dominated the market in 2020. Retail chains across the world are investing in advanced technologies and undertaking new initiatives in order to improve sales and attract more customers. The increasing sales of e-cigarettes through vape shops and retail stores is another factor augmenting the growth of this segment
• Asia Pacific held the largest market share in 2020. Favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products, are supporting continual growth

Nicotine Replacement Therapy Market Segmentation

Grand View Research has segmented the global nicotine replacement therapy market by product, distribution channel, and region:

NRT Product Outlook (Revenue, USD Billion, 2017 - 2028)

• Nicotine Replacement Therapy
  • Inhalers
  • Gum
  • Transdermal Patches
  • Sublingual Tablets
  • Lozenges
  • Others
• E-cigarettes
• Heat-not-burn Tobacco Products

NRT Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2028)

• Offline
• Online

NRT Regional Outlook (Revenue, USD Billion, 2017 – 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Nicotine Replacement Therapy Market

• Philip Morris Products S.A. (Altria Group)
• British American Tobacco p.l.c.
• Japan Tobacco, Inc.
• Imperial Brands
• Glenmark
• Fertin Pharma
• Cipla Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wires And Cables Market Competitive Insight and Key Drivers 2021 to 2028

 Wires And Cables Market Growth & Trends

The global wires and cables market size is expected to reach USD 260.16 billion by 2028, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 4.4% from 2021 to 2028. Wires and cables are one of the essential components of infrastructure development across the world. The growing emphasis on investments and government initiatives to generate power from renewable sources has enforced the adoption of wires and cables across the globe. Increasing funds in the upgradation of infrastructure and the demand for refined power transmission and distribution systems are the key factors driving the market over the forecast period.

Infrastructure development, modernization, and upgradation of infrastructure such as railways, tunnels, tunnel-lighting and signaling; commercial, residential, and industrial buildings; and implementation of smart grid technology is expected to drive the global market. Sectors such as defense, aerospace, and telecom are moving towards new infrastructure and construction, which increases the demand for cables and wires across the globe. Technological upgrades require various services, such as internet access and communication. Expansions and upgrades will directly increase the demand for cables such as communication cables, instrumentation cables, Ethernet cables, and others.

The government initiatives in rural electrification also play a vital role in the growth of the overall market. Rural electrification entails actions, including setting electricity infrastructure, improving communication, and providing connectivity to households. Rural electrification is anticipated to drive the demand for wires and cables in the coming years. For instance, according to the Ministry of Power - Government of India, 26.3 million homes below the poverty line have been electrified under the Rural Electrification section of Deen Dayal Upadhyay Gram Jyoti Yojana (DDUGJY). Smart grids diminish the general cost incurred in traditional systems, including the operational cost encountered due to loss of power. It also lowers the pressure on energy prices and total customer bills. The Indian government, under the "Make in India" campaign, has targeted the installation of 130 million smart meters by 2021 under Smart City Initiatives. The installation was done at the consumer base, where the monthly consumption is above 200 units by 2019. There are various steps taken by the government in other countries, such as the U.S., to encourage the smart grid implementation.

Request a free sample copy or view report summary: Wires And Cables Market Report

Wires And Cables Market Report Highlights

• The global market accounted for USD 183.14 billion in 2020 and is expected to grow at a CAGR of 4.4% from 2021 to 2028. 
• The extra-high voltage segment emerged as the fastest-growing segment over the forecast period. 
• Overhead emerged as the largest segment in 2020 and is estimated to generate revenue of over USD 165.17 billion by 2028. 
• The Asia Pacific market held the largest share in the market in 2020. Government initiatives such as Make in India and Smart Cities in the region are anticipated to drive the market.
• Key players including Prysmian SpA, Nexans, Belden Inc., LS Cables & System Ltd., Furukawa Electric Co., Ltd., Fujikura Ltd., Sumitomo Corporation, Leoni AG, NKT A/S, among others accounted for the majority share of the overall market in 2020.

Wires and Cables Market Segmentation

Grand View Research has segmented the global wires and cables market on the basis of voltage, installation, end-use, and region:

Wires And Cables Voltage Outlook (Revenue, USD Billion, 2017 - 2028)

• Low Voltage
• Medium Voltage
• High Voltage
• Extra High Voltage

Wires And Cables Installation Outlook (Revenue, USD Billion, 2017 - 2028)

• Overhead
• Underground

Wires And Cables End-use Outlook (Revenue, USD Billion, 2017 - 2028)

• Aerospace & Defense
• Building & Construction
• Oil & Gas
• Energy & Power
• IT & Telecommunication
• Others

Wires And Cables Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• South America
  • Brazil
• Middle East & Africa

List of Key Players of Wires And Cables Market

• Belden Inc.
• Fujikura Ltd.
• Furukawa Electric Co., Ltd.
• Leoni AG
• LS Cables & System Ltd.
• Nexans
• NKT A/S
• Prysmian SpA
• Sumitomo Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Augmented Reality Market Top Players, Analysis And Forecast Till 2028: Grand View Research Inc.

 Augmented Reality Market Growth & Trends

The global augmented reality market size is estimated to reach USD 340.16 billion by 2028, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 43.8% from 2021 to 2028. Continued innovations in the Augmented Reality (AR) realm, which have triggered the adoption of the technology in several industries and industry verticals, is fueling market growth. People are increasingly adopting the AR-supported online platforms for shopping, education, and social media interactions, among other purposes, for a better immersion experience. The introduction of Website-based AR (WebAR), a digital technology that allows users to directly access AR on the internet without having to download any application, is expected to create substantial opportunities for the market growth.

E-commerce sales are on the rise as brick and mortar retail stores remain temporarily shut, in various parts of the world in the wake of the COVID-19 pandemic. Hence, several businesses are launching new products online and adopting AR technology to provide an immersive experience to buyers. AR and 3D visualization are allowing consumers to experience products virtually in real time before making a buying decision.

The adoption of AR technology in the education industry is also gaining traction owing to the potential of the technology to help students in experiencing a more detailed and live explanation of informative concepts. The adoption of augmented reality in the education industry is poised for significant growth over the forecast period as several educational institutions are shifting their courses and lectures to virtual event platforms in the wake of the COVID-19 pandemic.

Request a free sample copy or view report summary: Augmented Reality Market Report

Augmented Reality Market Report Highlights

• Smartphone proliferation and widescale adoption of AR in mobile games are expected to drive the growth of the market
• The handheld devices display segment is anticipated to exhibit the highest CAGR of over 45.0% from 2021 to 2028
• The industrial and manufacturing application segment accounted for the highest revenue share in 2020
• The Asia Pacific regional market is expected to register the highest CAGR over the forecast period

Augmented Reality Market Segmentation

Grand View Research has segmented the global augmented reality market based on component, display, application, and region:

AR Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware
• Software

AR Display Outlook (Revenue, USD Million, 2016 - 2028)

• HMD & Smart Glass
• HUD
• Handheld Devices

AR Application Outlook (Revenue, USD Million, 2016 - 2028)

• Aerospace & Defense
• Automotive
• Education
• E-commerce & Retail
• Gaming & Entertainment
• Healthcare
• Industrial & Manufacturing
• Others

AR Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players in the Augmented Reality Market

• Google, LLC
• Sony Corporation
• Facebook LLC
• Magic Leap, Inc.
• Samsung Electronics Co., Ltd.
• HTC Corporation
• Wikitude GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Gypsum Board Market Expected To Hit CAGR of 11.8% By 2028

 

Gypsum Board Market Growth & Trends

The global gypsum board market size is expected to reach USD 109.95 billion by 2028 registering a CAGR of 11.8%, according to a new report by Grand View Research Inc. Increasing utilization of gypsum boards in decorative and partitioning applications in residential constructions is anticipated to drive the market over the forecast period. Rise in the construction industry across the globe is likely to provide growth opportunities to the market. The product demand is also driven by the residential sector, wherein, it is widely used for room partitioning.

These products are available in the form of wallboards, ceiling boards, pre-decorated boards, etc., which also boosts their demand in the construction application. Moreover, high durability and low weight of the product coupled with easy handling measures have propelled its demand in commercial, institutional, and industrial facilities for impact & mold resistance, exterior sheathing, and shaft wall constructions. Moreover, the availability of decorative designs on the boards is likely to support the growth over the forecast period. The U.S. Environmental Protection Agency (EPA) has approved the use of Flue Gas Desulphurization (FGD) Gypsum as a substitute to mined gypsum for the production of wallboards.

Request a free sample copy or view report summary: Gypsum Board Market Report

Gypsum Board Market Report Highlights

• The wallboard segment led the global market in 2020 and will expand at a steady CAGR over the projected period owing to the wide utilization of wallboards in partitioning and decorative applications, majorly in multi-family residential constructions
• In 2020, the residential application segment dominated the global market with a share of over 47% and is projected to ascend at the fastest CAGR over the forecast period
• The residential application segment growth can be attributed to the rising need for the construction of multi-family houses in regions, such as Asia Pacific and North America
• North America accounted for the largest market share of over 42% in 2020 on account of the well-established construction industry and quick adoption of advanced construction materials
• Saint-Gobain was the leading market player with gypsum solutions offered under brands, such as CertainTeed, British Gypsum, Gyproc, Rigips, and Placo

Gypsum Board Market Segmentation

Grand View Research has segmented the global gypsum board market on the basis of product, application, and region:

Gypsum Board Product Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• Wallboard
• Ceiling Board
• Pre-decorated Board
• Others

Gypsum Board Application Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• Pre-engineered Buildings
• Residential
• Industrial
• Commercial
• Institutional

Gypsum Board Regional Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
• Middle East & Africa
  • Bahrain
  • Kuwait
  • Qatar
  • Oman
  • Saudi Arabia
  • UAE
  • Jordan
  • Iraq
  • Iran
  • Egypt
  • Syria
  • Turkey
  • Libya
  • Sudan

List of Key Players of Gypsum Board Market

• Saint-Gobain Gyproc
• Knauf Gips KG
• Gulf Gypsum Co.
• USG Corp.
• National Gypsum Company
• LafargeHolcim Ltd.
• Georgia-Pacific LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Next Generation Sequencing Market Poised to Expand at a Robust Pace of $11.7 Billion Over 2028

 

Next Generation Sequencing Market Growth & Trends

The global next generation sequencing market size is anticipated to reach USD 11.7 billion by 2028 registering a CAGR of 14.4%, according to a new report by Grand View Research, Inc. As researchers are continuously unlocking the genetic diversity, the development of targeted therapies is on the rise. These therapies are targeted towards narrow populations of patients that have specific or rare genomic biomarkers. Therefore, this is expected to increase the utilization of next generation sequencing (NGS) technology for targeted therapies.

Simplification in the NGS workflow coupled with the continued price reductions in instruments as well as reagents is attributed to the increasing adoption of this technology. The cost of sequencing the human genome has reduced from USD 100 million to less than USD 1,000 in less than two decades. Moreover, enhancement in the bioinformatics capabilities will lead to broadening of NGS adoption at the low- and high-throughput ends of the research market.

Several companies are engaged in the innovation of long-read sequencing technologies, which will augment the research as well as clinical application sets. The growing automation in the pre- & post-sequencing protocols, and data analysis is also driving the market. The utilization of novel platforms for the development of personalized medicine at a genetic level is also a significant factor, which is expected to boost the demand for NGS over the forecast period.

Request a free sample copy or view report summary: Next Generation Sequencing Market Report

Next Generation Sequencing Market Report Highlights

• The oncology application segment accounted for the largest revenue share in 2020 and will retain its dominance throughout the forecast period due to the development and launch of targeted gene panels for oncology
• Companies like Myriad Genetics, Inc., through its myRisk product, offer genetic testing to identify people who may be at a higher risk of developing certain cancers in the future
• The high utility of NGS technology in the identification of coronavirus strains is expected to drive the infectious diseases segment with the fastest CAGR from 2021 to 2028
• Sequencing was the largest revenue-generating workflow segment in 2020 due to the introduction of novel, portable sequencers as a result of high competition
• In addition, owing to the expected increase in adoption and usage of WGS, sequencing is expected to witness the fastest CAGR over the forecast period
• The clinical research end-use segment is expected to register the fastest CAGR from 2021 to 2028. An increase in the utility of NGS technology and the support of key players for Covid-19 research is responsible for the segment growth
• For instance, in January 2021, to support the Covid-19 surveillance and research, Thermo Fisher Scientific extended its SARS-CoV-2 GlobalAccess Sequencing Program to offer additional units of Ion GeneStudio S5 sequencer and Ion Torrent Genexus System at a subsidized rate
• North America was the largest regional market owing to significant developments in the fields of companion diagnostics, personalized medicine, and NGS
• Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2028 owing to the expansion of the molecular diagnostics field and high investments by global and local players in the Asian countries
• For instance, in January 2021, Crown Bioscience, Inc.; a U.S.-based platform technology innovator; launched NGS panel services at its Center of Translational Science in Suzhou, China

Next Generation Sequencing Market Segmentation

Grand View Research has segmented the global next generation sequencing market on the basis of technology, application, workflow, end-use, and region:

NGS Technology Outlook (Revenue, USD Million, 2017 - 2028)

• WGS
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing
  • DNA-based
  • RNA-based

NGS Application Outlook (Revenue, USD Million, 2017 - 2028)

• Oncology
  • Diagnostics and Screening
    • Oncology Screening
      • Sporadic Cancer
      • Inherited Cancer
    • Companion Diagnostics
    • Other Diagnostics
  • Research Studies
• Clinical Investigation
  • Infectious Diseases
  • Inherited Diseases
  • Idiopathic Diseases
  • Non-Communicable/Other Diseases
• Reproductive Health
  • NIPT
    • Aneuploidy
    • Microdeletions
  • PGT
  • Newborn Genetic Screening
  • Single Gene Analysis
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Agrigenomics & Forensics
• Consumer Genomics

 NGS Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Pre-Sequencing
  • NGS Library Preparation Kits
  • Semi-automated Library Preparation
  • Automated Library Preparation
  • Clonal Amplification
• Sequencing
• NGS Data Analysis
  • NGS Primary Data Analysis
  • NGS Secondary Data Analysis
  • NGS Tertiary Data Analysis

NGS End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

NGS Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Italy
  • Spain
  • France
• Asia Pacific
  • Japan
  • China
  • South Korea
  • Australia
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Next Generation Sequencing Market

• Illumina
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies
• Genomatix GmbH
• PierianDx
• DNASTAR, Inc.
• Eurofins GATC Biotech GmbH
• Perkin Elmer, Inc.
• BGI
• Bio-Rad Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Laboratory Service Market Soaring Demand Assures Motivated Revenue Share By 2028

 Clinical Laboratory Service Market Growth & Trends

The global clinical laboratory service market size is expected to reach USD 288.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.7% from 2021 to 2028. Growing prevalence of target diseases such as diabetes and cardiovascular diseases is expected to positively impact the market growth over the forecast period. For instance, according to the WHO, by 2030, cardiovascular diseases are estimated to cause approximately 23.6 million deaths, mainly from heart disease and stroke.

The COVID-19 pandemic, caused due to SARS-CoV-2, is affecting millions of people globally. According to WHO and CDC, the standard for laboratory diagnosis of COVID-19 is Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for samples collected from the respiratory tract. The adoption of PCR technology for the diagnosis of COVID-19 and the genetic sequencing of the virus for the development of a cure are driving the market.

Furthermore, in May 2020, the Department of Health and Human Services (HHS) provided more than USD 200 million to clinics in rural areas of the U.S. to expedite COVID-19 testing. Such robust investments by government bodies to increase adoption of COVID-19 diagnostic kits by clinics are anticipated to boost segment growth. COVID-19 walk-up clinics in San Jose are another key initiative expected to positively impact segment growth.

In addition, advancements in laboratory testing technology through incremental and breakthrough developments are expected to serve this market as a high impact rendering driver. For instance, in March 2020, a Singapore-based med-tech company, Biolidics, launched a rapid test kit for COVID-19 and entered into a manufacturing agreement with a diagnostic kit manufacturer for mass production.

Automation in clinical settings has significantly improved the data management process in labs. Improving adoption rates of laboratory automation systems is expected to boost the market throughout the forecast period. Furthermore, database management tools, patient test records, and integrated workflow management systems have received significant consideration in the healthcare industry.

Request a free sample copy or view report summary: Clinical Laboratory Service Market Report

Clinical Laboratory Service Market Report Highlights

• In 2020, the clinical chemistry segment held majority of revenue share owing to presence of large number of tests due to increasing knowledge on clinical chemistry
• Stand-alone laboratories is expected to witness lucrative growth rate over the forecast period due to introduction of digital support systems to manage large databases and ability to provide better clinical laboratory services at a comparatively lower rate
• The bioanalytical and lab chemistry services segment dominated the market in 2020 owing to rising use of wide range of techniques and technology platforms to fulfill diagnostic needs
• In Asia Pacific, the market is projected to witness the fastest growth over the forecast period owing to a growing awareness, increased government initiatives, and positive regulatory policies
• North America dominated the market in 2020 due to technological advancements and high awareness on medical standards

Clinical Laboratory Service Market Segmentation

Grand View Research has segmented the global clinical laboratory service market on the basis of test type, service provider, application, and region:

Clinical Laboratory Services Test Type Outlook (Revenue, USD Billion, 2017 - 2028)

• Human & Tumor Genetics
• Clinical Chemistry
• Medical Microbiology & Cytology
• Other Esoteric Tests

Clinical Laboratory Services Provider Outlook (Revenue, USD Billion, 2017 - 2028)

• Hospital-Based Laboratories
• Stand-Alone Laboratories
• Clinic-Based Laboratories

Clinical Laboratory Services Application Outlook (Revenue, USD Billion, 2017 - 2028)

• Bioanalytical & Lab Chemistry
• Toxicology Testing
• Cell & Gene Therapy Related Services
• Preclinical & Clinical Trial Related Services
• Drug Discovery & Development Related Services
• Others

Clinical Laboratory Services Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Colombia
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Clinical Laboratory Service Market

• Qiagen
• OPKO Health, Inc.
• Charles River Laboratories
• International, Inc
• Sonic Healthcare
• Almac Group
• Laboratory Corporation of America Holdings (LabCorp)
• DaVita, Inc.
• Viapath Group LLP
• Abbott
• SGS SA
• Quest Diagnostics, Inc.
• NeoGenomics Laboratories, Inc.
• Siemens Healthcare GmbH
• Fresenius Medical Care
• Cinven
• Arup Laboratories

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Anti-acne Cosmetics Market Booming Trends and Forecast Assessment for the Period 2021 to 2028

 Anti-acne Cosmetics Market Growth & Trends

The global anti-acne cosmetics market size is expected to reach USD 4.7 billion by 2028 registering a CAGR of 9.1%, according to a new report by Grand View Research, Inc. The high psychological burden associated with acne, especially among women, is expected to be the key growth-driving factor for the market. Moreover, the easy availability of various products to treat acne is anticipated to support the market growth. According to the American Academy of Dermatology, it is one of the common skin disorders in the U.S., affecting approximately 50 million individuals every year, with nearly 85% of individuals between the age group of 12 and 24 years having minor acne. Thus, a high prevalence of this skin disorder is also anticipated to fuel the product demand, thereby augmenting the market growth.

Furthermore, according to a study conducted by SkinStore, an average American woman uses nearly 16 skincare products per day and spends approximately USD 8 each day on facial cosmetics products. Such beauty regimes are also anticipated to propel market growth. According to the University of Limerick study, the negative social stigma associated with this skin disorder reduces the quality of life of individuals, increases their psychological distress, and causes physical problems, such as headaches, sleep disturbance, and gastrointestinal issues. This is also anticipated to increase the product demand over the coming years.

Request a free sample copy or view report summary: Anti-acne Cosmetics Market Report

Anti-acne Cosmetics Market Report Highlights

• The creams & lotions segment dominated the market in 2020 as the cream is the first line of therapy for all types of acne and it also provides skin moisturization
• The others product segment is expected to register the fastest CAGR over the forecast period due to the lightness of these products on the skin and compatibility with various skin types as compared to creams & lotions
• The women end-use segment held dominated share of the market in 2020 and is expected to grow at the fastest CAGR during the forecast period owing to a high prevalence of acne and other skin disorders
• Asia Pacific is anticipated to be the largest as well as the fastest-growing regional market from 2021 to 2028 due to increasing disposable income levels and growing population in developing countries

Anti-acne Cosmetics Market Segmentation

Grand View Research has segmented the global anti-acne cosmetics market on the basis of product type, end-use, and region:

Anti-acne Cosmetics Product Type Outlook (Revenue, USD Million, 2016 - 2028)

• Mask
• Creams & Lotions
• Cleansers & Toners
• Others

Anti-acne Cosmetics End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Women
• Men

Anti-acne Cosmetics Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Anti-acne Cosmetics Market

• Neutrogena
• Clinique
• Murad
• Kose
• LaRochPosay
• Mentholatum
• L'Oréal
• Proactiv
• Vichy

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Central Nervous System Therapeutic Market is Thriving USD 205.0 Billion Revenue by 2028

 Central Nervous System Therapeutic Market Growth & Trends

The global central nervous system therapeutic market size is expected to reach USD 205.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. High unmet medical needs and government initiatives to reduce the disease burden are driving the market for central nervous system (CNS) therapeutic over the forecast period. According to WHO, the global economy loses due to depression and anxiety is more than USD 1 trillion per year and rising patient base of mental health globally is expected to increase the economy loses by USD 16 trillion in 2030.

The market holds strong future growth opportunities and major players are adopting different marketing strategies such as new product development, collaborations, geographic expansion, mergers and acquisitions, and new product approval, to strengthen their positions. In February 2020, Biogen announced the investment in Sangamo’s zinc finger platform to develop therapies for Alzheimer’s disease and other neurological diseases. Similarly, the company has an agreement with Ionis Pharmaceutical for the development of drug candidates applicable across a wide range of neurological diseases.

Presence of strong pipeline products by major pharmaceutical companies such as Biogen, H. Lundbeck A/S, Eli Lilly and Company, and others are expected to accelerate market growth over the forecast period. Besides, other pharmaceutical companies are also actively involved in the development of novel therapies and investing heavily to develop effective therapeutics for the treatment of CNS associated diseases.

Most of the late phase development drugs are for the treatment of neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis. The drug candidates such as aducanumab, brexpiprozole, evobrutinib, solanezumab are some of the potential drugs that could be commercialized in the next five to eight years for the treatment of various indication of neurodegenerative disorders. Apart from neurodegenerative diseases, migraine, schizophrenia, and epilepsy are the major CNS disease indications that have potential drug candidates in pipeline.

The cancer segment is expected to witness the fastest growth rate over the forecast period. Increasing prevalence, high mortality rate, and rising demand for effective treatment are expected to fuel the growth of the market for CNS therapeutic. According to National Cancer Institute estimates, the number of new cases of CNS cancers was 23,890 whereas the number of deaths was 18,020 in the U.S. in 2020.

Pharmaceutical companies are adopting strategies such as product development, merger and acquisition, and collaboration to strengthen their position in market. For instance, Biogen has signed agreements with Ionis Pharmaceuticals, Atalanta Therapeutics, and Sangamo Therapeutics to develop novel therapeutics for the treatment of different disease indications of the central nervous system. Similarly, in January 2020, the CNS Pharmaceuticals has entered into a licensing agreement with MD Anderson Cancer Center to investigate WP1244, a designed DNA-binding agent to cross the blood-brain barriers for the potential treatment of brain cancers.

Request a free sample copy or view report summary: Central Nervous System Therapeutic Market Report

Central Nervous System Therapeutic Market Report Highlights

• The neurodegenerative diseases segment accounted for the largest revenue share of nearly 40.0% in 2020 and is anticipated to maintain its dominance over the forecast period
• Pipeline candidates such as aducanumab, brexpiprozole, evobrutinib, solanezumab are anticipated to drive the neurodegenerative disorder segment from 2021 to 2028
• The CNS cancer segment is expected to witness the fastest growth rate over the forecast period. Increasing demand for effective treatment is expected to drive the segment
• In Asia Pacific, the market is estimated to witness the fastest growth over the coming years owing to the increase in treatment rate and betterment of healthcare infrastructure in the region
• North America held a majority of share in 2020 due to high awareness level in the region and better reimbursement scenario

Central Nervous System Therapeutic Market Segmentation

Grand View Research has segmented the global central nervous system therapeutic market on the basis of disease and region:

CNS Therapeutic Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Neurovascular Diseases
• CNS Trauma
• Mental Health
  • Anxiety Disorders
  • Epilepsy
  • Mood Disorders
  • Psychotic Disorders
  • Others
• Neurodegenerative Diseases
  • Alzheimer's Disease
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Huntington's Disease
  • Amyotrophic Lateral Sclerosis
  • Others
• Infectious Diseases
• CNS Cancer
• Others

CNS Therapeutic Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Central Nervous System Therapeutic Market

• Biogen
• Otsuka Pharmaceutical Co., Ltd.
• Eli Lilly and Company
• Merck & Co.
• Astra Zeneca
• Shire PLC
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson Services, Inc.
• Pfizer, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Rapid Medical Diagnostic Kits Market To Hold a High Potential for Growth by 2028

 Rapid Medical Diagnostic Kits Market Growth & Trends

The global rapid medical diagnostic kits market size is expected to reach USD 18.0 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.4% from 2021 to 2028. Rapid medical diagnostic kits enhance the speed of etiologic diagnosis of patients affected with chronic ailments. Moreover, speedy diagnosis is of paramount importance in individuals affected with infectious diseases. Thus, an increase in the number of manufacturers keen on exploring this space is driving the revenue in the market.

Key players are focusing on introducing novel medical supplies that require limited operational training, offer convenient usage, and ensure effective analysis. This is expected to propel the demand for rapid medical care among the industry’s target audience, which is inclusive of a general population affected with chronic diseases, coupled with the healthcare professionals determined to recommend an appropriate rapid medical evaluation.

The gradual shift toward point of care (POC) testing is also an important factor boosting the adoption of these test kits. Moreover, the recent pandemic outbreak of COVID-19 has piqued the interest of healthcare professionals in this industry space. High demand for portable testing kits in COVID-19 diagnostics is expected to make a significantly positive impact on the market expansion during the forecast period.

Novel rapid diagnostic tests are being developed that are expected to facilitate the prevention of infections along with antimicrobial stewardship. Newly developed tests are combined with Antimicrobial Stewardship (ASP) to optimize antimicrobial utilization as well as patient outcomes. Moreover, test kits with a broad scope of diagnosis and swift turnaround time are entering the space, offering lucrative opportunities for revenue growth.

For instance, in January 2021, Trinity Biotech’s Captia SARS-CoV-2 IgG ELISA rapid test secured the CE mark. The company has also stated that it has significant capacity for ELISA associated product manufacturewithin their current operations, aiding in speedy commercialization of this test kit across the globe.

Request a free sample copy or view report summary: Rapid Medical Diagnostic Kits Market Report

Rapid Medical Diagnostic Kits Market Report Highlights

• By product, over the counter (OTC) kits dominated the market in 2020 with a share of 54.3%. This is attributed to the routine adoption of OTC rapid diagnostic tests to ensure timely administration of an apt therapeutic intervention
• On the basis of technology, the lateral flow segment held the largest share of 35.1% in 2020. Convenient manufacturing protocols, coupled with low costs associated with the development, have led to the expansion of lateral flow assays into the rapid medical diagnostic market space
• The blood glucose testing application segment is estimated to expand at the fastest CAGR of 4.1% from 2021 to 2028. The imperative need for routine blood glucose monitoring in diabetic patients has contributed to the segment’s revenue generation capacity
• Based on end use, hospitals and clinics accounted for the largest revenue share in 2020 owing to the maximum adoption of rapid medical diagnostic kits
• Market entities are actively participating in the development of rapid medical test products to address the current pandemic outbreak of COVID-19, further intensifying the market competition

Rapid Medical Diagnostic Kits Market Segmentation

Grand View Research has segmented the global rapid medical diagnostic kits market on the basis of product, technology, application, end use, and region:

Rapid Medical Diagnostic Kits Product Outlook (Revenue, USD Million, 2017 - 2028)

• Over the Counter (OTC) Kits
• Professional Kits

Rapid Medical Diagnostic Kits Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Lateral Flow
• Agglutination
• Solid Phase
• Other Technologies

Rapid Medical Diagnostic Kits Application Outlook (Revenue, USD Million, 2017 - 2028)

• Blood Glucose Testing
• Infectious Disease Testing
• Cardiometabolic Testing
• Pregnancy and Fertility Testing
• Fecal Occult Blood Testing
• Coagulation Testing
• Toxicology Testing
• Lipid Profile Testing
• Other Applications

Rapid Medical Diagnostic Kits End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Hospitals & Clinics
• Home Care
• Diagnostic Laboratories

Rapid Medical Diagnostic Kits Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Rapid Medical Diagnostic Kits Market

• ACON Laboratories, Inc.
• Abbott Laboratories
• Artron Laboratories Inc.
• Alfa Scientific Designs, Inc.
• Becton, Dickinson and Company
• BTNX, Inc.
• bioMérieux SA
• Cardinal Health
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Creative Diagnostics
• Meridian Bioscience, Inc.
• Hoffmann-La Roche AG
• McKesson Medical-Surgical, Inc
• Sight Diagnostics Ltd
• Trinity Biotech
• Zoetis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nicotine Replacement Therapy Market Precise Analysis on Business Overview, Product Scope And Ongoing Development

 Nicotine Replacement Therapy Market Growth & Trends

The global nicotine replacement therapy market size is expected to reach USD 147.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.3% from 2021 to 2028. The growth of the market is largely attributed to increasing government initiatives to promote nicotine replacement therapy (NRT) products for reducing mortality due to smoking and diseases associated with it.

Smoking cessation campaigns are also playing a crucial role in increasing awareness about diseases that are caused because of smoking. These campaigns are run by regional governments as well as multinational companies, such as Philip Morris International and Altria. Global organizations like the WHO are also working toward creating awareness by running online campaigns. 

There has been an exponential increase in the usage of NRT products. The young population is the largest consumer of advanced NRT products, like heat-not-burn tobacco and e-cigarettes. However, middle-aged patients’ interest in smoking cessation has led to a rise in the usage of e-cigarettes. For instance, the use of e-cigarettes for smoking cessation increased to 20% in 2018 from 13% in 2016 among people aged 45 to 54 years.

Furthermore, researchers found that 5% to 9% of smokers tend to use nicotine patches even after the therapeutic period of 12 weeks. The passive approach of combining nicotine patches with a gum, inhaler, or spray is found to be more effective, and quitting rate reaching 34% to 54%. NRT is only recognized as a way of curbing nicotine cravings and treatment by consumers.

With technological advancements, the players in this market are also developing products to suit the changing consumer preferences. For instance, the e-cigarette market is changing with newer innovations that are more efficient, have longer battery life, and are rechargeable. The existing innovations like sleek and easy-to-use socially acceptable e-cigarettes brought a revolution, which drove more people to shift to using NRTs without social stigma.

Various players such as Nicocigs Ltd.; Nicoventures Ltd.; Victory Electronic Cigarettes Corp.; DuraSmoke; AlternaCig; Shenzhen IVPS Technology CO. Limited; and Vapor Group, Inc. are launching e-cigarettes and related products. Although there are hundreds of companies selling e-cigarettes, their usage in NRT is disputed.

Request a free sample copy or view report summary: Nicotine Replacement Therapy Market Report

Nicotine Replacement Therapy Market Report Highlights

• By product, the e-cigarettes segment held the largest NRT market share in 2020 due to increasing investments and the rising focus of companies on developing value-added products. The heat-not-burn tobacco products segment is expected to grow at the fastest rate over the forecast period
• The offline distribution channel segment dominated the market in 2020. Retail chains across the world are investing in advanced technologies and undertaking new initiatives in order to improve sales and attract more customers. The increasing sales of e-cigarettes through vape shops and retail stores is another factor augmenting the growth of this segment
• Asia Pacific held the largest market share in 2020. Favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products, are supporting continual growth

Nicotine Replacement Therapy Market Segmentation

Grand View Research has segmented the global nicotine replacement therapy market by product, distribution channel, and region:

NRT Product Outlook (Revenue, USD Billion, 2017 - 2028)

• Nicotine Replacement Therapy
  • Inhalers
  • Gum
  • Transdermal Patches
  • Sublingual Tablets
  • Lozenges
  • Others
• E-cigarettes
• Heat-not-burn Tobacco Products

NRT Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2028)

• Offline
• Online

NRT Regional Outlook (Revenue, USD Billion, 2017 – 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Nicotine Replacement Therapy Market

• Philip Morris Products S.A. (Altria Group)
• British American Tobacco p.l.c.
• Japan Tobacco, Inc.
• Imperial Brands
• Glenmark
• Fertin Pharma
• Cipla Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thermal Paper Market to Reach USD 6.03 Billion by 2028

 Thermal Paper Market Growth & Trends

The global thermal paper market size is expected to reach USD 6.03 billion by 2028 registering a CAGR of 5.2%, according to a new report by Grand View Research Inc. The growing product usage in tags & labels in the food & beverages and pharmaceutical industries is expected to drive the market growth over the forecast period. The rapid growth of the retailing industry in India, China, Indonesia, Brazil, UAE, and Saudi Arabia is boosting the use of retail transactions through PoS terminals. In addition, strict labeling norms in the food & beverages and pharmaceutical industries are further expected to boost the product demand.

The growing popularity of the gaming and casino industry across the world is also expected to provide a significant boost to the global market. Las Vegas, Singapore, and Macao are some of the most popular destinations that have gained prominence due to their gaming and casino industry. Increasing footfall at these places is expected to prove beneficial to the market growth. Companies in the Asia Pacific, particularly in Japan, have established their production units as well as strategic business channels in Europe and the U.S to cater to the buyers at the domestic level. Some of the manufacturers have formed partnerships with local roll converters for ensuring product supply to their consumers.

Request a free sample copy or view report summary: Thermal Paper Market Report

Thermal Paper Market Report Highlights

• In China, the tags & label segment is expected to grow at a CAGR 6.9% over the forecast period on account of growing product adoption in tags & labels in the food & beverages and retailing industries of the country
• In 2020, the revenue for the PoS application segment in the North America region stood at USD 709.6 million owing to the wide use of PoS machines at supermarkets, cafeterias, gas stations, and retail stores
• In Germany, the market is anticipated to reach USD 264.7 million by 2028 on account of increasing product usage in tags & labels for inventory management purposes in the regional manufacturing industry
• The PoS application segment in India is expected to register a CAGR of 11.4% over the forecast owing to the continued efforts by the Government of India to promote various types of cashless transaction modes
• With the growing restrictions of Bisphenol A-based products, manufacturers are progressively launching phenol-free thermal paper products in key markets

Thermal Paper Market Segmentation

Grand View Research has segmented the global thermal paper market on the basis of application and region:

Thermal Paper Application Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Point-of-Sale (PoS)
• Lottery & Gaming
• Tags & Labels
• Others

Thermal Paper Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia

List of Key Players of Thermal Paper Market

• Ricoh Company, Ltd.
• Oji Holdings Corporation
• MPM Ltd.
• Appvion Incorporated
• Jujo Thermal Ltd.
• Lecta Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Home Infusion Therapy Market Expected To Trigger A Revenue To USD 44.7 Billion By 2028: Grand View Research, Inc.

 Home Infusion Therapy Market Growth & Trends

The global home infusion therapy market size is expected to reach USD 44.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% from 2021 to 2028. Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biological products to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on market growth. According to a report by the WHO, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth.

The ongoing COVID-19 pandemic is expected to create lucrative opportunities for the market. Due to restrictions caused by COVID-19, patients are waiting to seek treatment until they feel safe. Moreover, patients who seek infusion therapy already have diseases that weaken their immune systems. In such cases, going outside even to receive treatment becomes a potential threat. Reduced operating hours have led to difficulty in scheduling appointments as well, even if patients choose to continue treatment. Hence, home infusion therapy is expected to play a key role in supporting patients.

Request a free sample copy or view report summary: Home Infusion Therapy Market Report

Home Infusion Therapy Market Report Highlights

• By product, the infusion pumps segment held the largest revenue share in 2020 owing to the increasing use of delivery fluids, such as nutrients and medications
• The anti-infective application segment dominated the market in 2020 as a large number of procedures are performed during the administration of medications, such as antibiotics and antifungals
• North America dominated the global market in 2020 owing to increasing demand for new technologies, along with advanced healthcare infrastructure
• The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of diabetic patients in the region

Home Infusion Therapy Market Segmentation

Grand View Research has segmented the global home infusion therapy market on the basis of product, application, and region:

Home Infusion Therapy Product Outlook (Revenue, USD Million, 2016 - 2028)

• Infusion Pumps
  • Elastomeric Pumps
  • Electromechanical
  • Gravity
  • Others
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

Home Infusion Therapy Application Outlook (Revenue, USD Million, 2016 - 2028)

• Anti-infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
  • Athletes
  • Others
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

Home Infusion Therapy Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Malaysia
  • Indonesia
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

List of Key Players of Home Infusion Therapy Market

• CVS/Coram
• Option Care Health
• BriovaRx/Diplomat (UnitedHealth Optum)
• PharMerica
• Fresenius Kabi
• ICU Medical, Inc.
• Braun Melsungen AG
• Baxter
• BD
• Caesarea Medical Electronics
• Smiths Medical
• Terumo Corporation
• JMS Co. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ophthalmic Drugs Market Size Is Expected To Reach USD 60.3 Billion by 2028

 Ophthalmic Drug Market Growth & Trends

The global ophthalmic drugs market size is expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. An increase in the prevalence of eye-related disorders, such as presbyopia, macular degeneration, and diabetic retinopathy, is one of the major drivers of the market. According to the American Academy of Ophthalmology, over 2.71 million people in the U.S. were affected by Primary Open-angle Glaucoma (POAG) in 2011, and the number is estimated to reach 7.3 million by 2050.

Moreover, due to COVID-19, it has become increasingly unsafe for individuals to touch their face several times a day, which is a known cause of transmission. Therefore, companies are developing long-acting, hands-free therapies to combat such challenges. For instance, in April 2020, Ocular Therapeutix, Inc. completed Phase III clinical trial to evaluate the safety and efficacy of DEXTENZA for allergic conjunctivitis. It is a hands-free therapy administered in the office setting as an intracanalicular insert. It is bioresorbable and designed to release the corticosteroid dexamethasone to the ocular surface, lasting 30 days. It is a one-time and long-acting therapy that can be useful during the COVID-19 crisis.

Investors are increasingly funding companies to support the clinical development of novel treatments for eye diseases thereby fueling the market growth. For instance, in February 2019, Oyster Point Pharma, Inc. received USD 93 million series B financing from Invus Opportunities, Flying L Partners, New Enterprise Associates (NEA), Versant Ventures, and Vida Ventures. The company’s product candidates include OC-01 and OC-02 in a Phase 2b clinical trial.

In addition, increasing development and approval of new laboratory methods is expected to boost the market growth. For instance, in July 2020, Quest Diagnostics received emergency Use Authorization (EUA) from the U.S. FDA for a laboratory technique that was developed for extracting viral RNA. This new technique was designed to expand the testing capacity of COVID-19 molecular tests.

Furthermore, key players in the market undertake various strategies to strengthen their product portfolios and offer diverse, technologically advanced, and innovative products. For instance, in September 2019, Alcon introduced iLUX Patient Care Kits to support practices in treating people with dry eyes in the U.S.

Request a free sample copy or view report summary: Ophthalmic Drug Market Report

Ophthalmic Drug Market Report Highlights

• In 2020, anti-VEGF agents dominated the market owing to high preference by ophthalmologists, enhanced tissue penetration, and rapid responsive rates
• Retinal disorders was the fastest-growing disease segment in 2020 owing to an increase in the prevalence of age-related macular degeneration and diabetic retinopathy, technological advancements, and rising strategic collaborations
• The topical route of administration dominated the market in 2020 due to the high patient compliance, non-invasiveness, and self-administrability
• The eye drops segment is estimated to witness the fastest growth over the forecast period due to impending launches of several ophthalmic solutions and suspensions in the near future and its direct drug delivery mechanism
• North America dominated the market and accounted for the largest revenue share in 2020 owing to the rising consumer awareness, high disease burden, technological advancements, and proactive government measures

Ophthalmic Drug Market Segmentation

Grand View Research has segmented the global ophthalmic drugs market on the basis of drug class, disease, dosage form, route of administration, product type, and region.

Ophthalmic Drugs Class Outlook (Revenue, USD Million, 2017 - 2028)

• Antiallergy
• Anti-VEGF Agents
• Anti-inflammatory
  • Nonsteroidal Drugs
  • Steroidal Drugs
• Antiglaucoma
• Others

Ophthalmic Drugs Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Dry Eye
• Eye Allergy
• Glaucoma
• Eye Infection
• Retinal Disorders
  • Macular Degeneration
  • Diabetic Retinopathy
  • Others
• Uveitis
• Others

Ophthalmic Drugs Dosage Form Outlook (Revenue, USD Million, 2017 - 2028)

• Gels
• Eye Solutions
• Capsules & Tablets
• Eye Drops
• Ointments

Ophthalmic Drugs Route of Administration Outlook (Revenue, USD Million, 2017 - 2028)

• Topical
• Local Ocular
  • Subconjunctival
  • Intravitreal
  • Retrobulbar
  • Intracameral
• Systemic

Ophthalmic Drugs Product Type Outlook (Revenue, USD Million, 2017 - 2028)

• Prescription Drugs
• OTC Drugs

Ophthalmic Drugs Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players of Ophthalmic Drugs Market

• Alcon
• Johnson & Johnson Services, Inc.
• Bausch Health
• Allergan
• Pfizer, Inc.
• Bayer AG
• Santen Pharmaceutical Co. Ltd.
• Genentech, Inc.
• Novartis AG
• Regeneron
• Merck & Co.
• Coherus Biosciences, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Digital Health Market to Expand at a CAGR of 15.1% Through 2028: Grand View Research Inc.

 Digital Health Market Growth & Trends

The global digital health market size is expected to reach USD 295.4 billion by 2028 and is projected to expand at a CAGR of 15.1% over the forecast period, according to a new report by Grand View Research, Inc. Rising smartphone penetration & integration of advanced technologies, such as the internet of things (IoT) & artificial intelligence (AI), and increasing implementation of mHealth technologies for self-management of chronic diseases, such as diabetes, are some of the major factors driving the market. In addition, increasing demand for enhancing workflow efficiency in clinics, hospitals, and other healthcare centers is further boosting the demand for mHealth services thereby, aiding the market growth.

Moreover, ongoing technological advancements for developing advanced digital solutions coupled with a growing number of favorable initiatives by the government & private sectors are contributing to the overall market growth. For instance, as per the data published in 2017, researchers at the University of Illinois have developed a camera to improve the diagnostic features of smartphones. In 2020, the mHealth technology type segment accounted for the highest revenue share. A rise in the number of health apps has significantly contributed to the segment growth in recent years. As per the data published by the My Health Apps blog in May 2018, a total of 325,000 health, fitness, and medical apps were available in 2017.

Mobile operators are constantly leveraging mHealth technologies and solutions by supporting services, such as diagnosis, monitoring, and patient management. In addition, they are increasingly adopting strategies in the form of partnerships and agreements to enhance their product offerings, which, in turn, is contributing to the segment growth. For instance, in 2019, OneLife, a mobile medical software company, partnered with AT&T for the development of a health-tracking watch to monitor a patient’s heart rate, location, sleep, and movements. In 2020, the services component segment accounted for the highest revenue share.

System integration, training & education, maintenance & support, and consulting are among the few service offerings that are covered in this segment. Growing demand for continuous M2P data flows, to boost the efficiency of the medical systems, improve informed decision-making in real-time, and enhance security, is driving the segment growth. On the other hand, software is anticipated to register the fastest growth during the forecast period. The key factors that can be attributed to this growth are rising investments by the market participants to develop innovative connected solutions for the healthcare industry, technological advancements, and rising adoption of digital technologies & connected systems in the health centers.

Request a free sample copy or view report summary: Digital Health Market Report

Digital Health Market Report Highlights

• The mHealth technology segment dominated the global market in 2020 owing to the increasing penetration of smartphones and rising number of strategic alliances among mobile operators & mHealth startups.
• The services component segment accounted for the highest revenue share of the global market in 2020
• North America was the leading regional market in 2020 owing to rise in the geriatric population and awareness regarding health & fitness among consumers
• High internet and smartphones penetration along with growing usage of medical/health-related apps is one of the key factors responsible for the market growth in North America
• However, APAC is expected to register the fastest CAGR from 2021 to 2028 due to the rising usage of tablets, smartphones, and other mobile platforms
• The rising geriatric population in countries, such as India and China, and the growing burden of chronic conditions are further boosting the demand for mHealth technologies in the region

Digital Health Market Segmentation

Grand View Research, Inc. has segmented the global digital health market on the basis of technology, component, and region

Digital Health Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Tele-healthcare
  • Tele-care
    • Activity Monitoring
    • Remote medication Management
  • Tele-health
    • LTC Monitoring
    • Video Consultation
  • mHealth
    • Wearables
      • BP Monitors
      • Glucose Meters
      • Pulse Oximeters
      • Sleep Apnea Monitors
      • Neurological Monitors
      • Activity Trackers/Actigraphs
    • mHealth Apps
      • Medical Apps
      • Fitness Apps
    • Services
    • mHealth Services Market, By Type
      • Monitoring services
        • Independent Aging Solutions
        • Chronic Disease Management & Post-acute Care Services
      • Diagnosis Services
      • Healthcare Systems Strengthening Services
      • Others
    • mHealth Services Market, By Participants
      • Mobile Operators
      • Device Vendors
      • Content Players
      • Healthcare Providers
    • Healthcare Analytics
    • Digital Health Systems
      • EHR
      • E-prescribing Systems

Digital Health Component Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Hardware
• Services

Digital Health Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • UAE
  • South Africa
  • Saudi Arabia

List of Key Players of Digital Health Market

• Cerner Corporation
• Allscripts
• Apple, Inc.
• Telefónica S.A.
• Mckesson Corporation
• Epic Systems Corporation
• QSI Management, LLC
• AT&T
• Vodafone Group
• AirStrip Technologies
• Google, Inc.
• Samsung Electronics Co., Ltd.
• HiMS
• Orange
• Qualcomm Technologies, Inc.
• Softserve
• MQure
• Computer Programs and Systems, Inc.
• Vocera Communications
• IBM Corporation
• CISCO Systems, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.